Search Results

A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test sytem to estimate test precision and to detect systematic analytivcal deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed or unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.

Not Found

The provided document is a 510(k) premarket notification letter for a Class I medical device (Wako NEFA Linearity Set), which is a quality control material. This type of device is significantly different from AI/ML-based diagnostic devices, and therefore, the information requested (acceptance criteria, study details, ground truth, expert involvement, MRMC studies, etc.) is not applicable or typically required for this classification.

Here is why most of the requested information cannot be found in this document for this specific device:

• Device Type: The Wako NEFA Linearity Set is a "Quality control material (assayed and unassayed)" for clinical chemistry. This means it's a substance used to check the performance of laboratory tests, not a diagnostic algorithm or imaging analysis tool.
• Regulatory Class: It's classified as Class I. Class I devices are subject to general controls and typically have a lower risk profile. They usually do not require extensive clinical studies or performance data like higher-class devices (Class II or III), especially not the kind of studies involving AI performance, human readers, or detailed ground truth establishment as defined for diagnostic algorithms.
• Document Content: The letter is an FDA 510(k) clearance letter, which states that the device is substantially equivalent to a legally marketed predicate device. It confirms the regulatory status and allows marketing but does not contain a detailed study report or performance data. The "Indications for Use" section further clarifies its purpose as a quality control material.

Therefore, I cannot provide the requested information in the format given because the nature of the device and the provided document do not support it.

To answer your request in general terms of what would be expected for an AI/ML-based diagnostic device, but acknowledging that this specific document and device do not provide it:

For an AI/ML-based diagnostic device, the requested information would typically be detailed in a separate clinical study report submitted as part of a 510(k) or PMA submission. That report would address:

1. Acceptance Criteria and Reported Device Performance: This would typically involve metrics like sensitivity, specificity, AUC, accuracy, positive predictive value (PPV), negative predictive value (NPV) against a defined ground truth, often with predefined thresholds for success (e.g., "The device must achieve a sensitivity of at least X% and specificity of at least Y%").
2. Sample Sizes and Data Provenance: Details about the number of cases (e.g., images, patient records) in the test set, the geographical origin of the data, and whether it was collected retrospectively or prospectively.
3. Number and Qualifications of Experts for Ground Truth: Quantification of how many human experts (e.g., N radiologists, M pathologists) established the ground truth, along with their specialty, years of experience, and board certifications.
4. Adjudication Method for Test Set: How disagreements among experts were resolved to establish a single ground truth (e.g., 2+1 means two initial readers, with a third expert adjudicating discrepancies).
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study: If conducted, this would compare human performance with and without AI assistance, reporting metrics like AUC improvement, reading time reduction, or changes in diagnostic accuracy. The effect size would quantify this improvement.
6. Standalone Performance: Evaluation of the algorithm's performance without human intervention.
7. Type of Ground Truth: The gold standard used (e.g., histology/pathology results, clinical outcomes, validated expert consensus, follow-up data).
8. Sample Size for Training Set: The number of cases used to train the AI model.
9. Ground Truth for Training Set: How the labels for the training data were established (often similar methods to the test set but might involve less rigorous adjudication for initial labeling).

In summary, the provided document pertains to a quality control material, not an AI/ML diagnostic device, and thus the specific detailed performance and study information for AI requested is not applicable nor present.

Ask a specific question about this device

The Wako NEFA Linearity set is to be used with the Wako NEFAC test kit for the estimation of the linearity limits of the reagent/instrument system for the NEFA analyte.

Not Found

I am sorry, but the provided text does not contain the detailed information necessary to answer your request about acceptance criteria and a study proving device performance. The document is an FDA 510(k) clearance letter for the "Wako NEFA Linearity Set," indicating it is substantially equivalent to a predicate device.

Specifically, the document mentions:

• Device Name: Wako NEFA Linearity Set
• Indications For Use: "The Wako NEFA Linearity set is to be used with the Wako NEFA C test kit for the estimation of the linearity limits of the reagent/instrument system for the NEFA analyte."

However, it does not include:

1. A table of acceptance criteria or reported device performance.
2. Details on sample sizes, data provenance, or study design.
3. Information about experts, ground truth establishment, or adjudication methods.
4. Reference to multi-reader multi-case (MRMC) comparative effectiveness studies.
5. Information about standalone algorithm performance.
6. Details on training set size or how its ground truth was established.

This document is a regulatory approval letter, not a technical study report. To get the information you are requesting, you would need to consult a separate study report or technical documentation for the Wako NEFA Linearity Set.

Ask a specific question about this device